CTD Holdings Inc.

CTD Holdings Inc.
Stock Exchange Other OTC
EPS
$0.06
Market Cap
$33.77 M
Shares Outstanding
91.26 M
Public Float
42.56 M

Profile

Address
6714 NW 16th Street
Gainesvile Florida 32563
United States
Employees -
Website http://www.ctd-holdings.com
Updated 07/08/2019
CTD Holdings, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product candidates include Trappsol Cyclo, which treats Neimann-Pick Type C disease. The company was founded by C.

Financials

View All

Nathan Scott Fine
Executive Chairman & Chief Executive Officer
Jeffrey L. Tate
Chief Operating Officer, Director & CSO